Increase in post-dialysis hemoglobin can be out of proportion and unrelated to ultrafiltration

Dialysis and Transplantation

Volumn 39, Issue 2, 2010, Pages 57-62

  Geller, Ari B ^a   DeVita, Maria V ^a   Marku Podvorica, Jehona ^a   Rosenstock, Jordan L ^a   Panagopoulos, Georgia ^a   Michelis, Michael F ^a  

^a LENOX HILL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ARTICLE; BODY WEIGHT; CORRELATION ANALYSIS; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; ULTRAFILTRATION;

EID: 77649278987     PISSN: 00902934     EISSN: 19326920     Source Type: Journal    
DOI: 10.1002/dat.20406     Document Type: Article

References (15)

1. Nissenson AR, Besarab A, Bolton WK, Goodkin DA, Schwab SJ. Target haematocrit during erythropoietin therapy. Nephrol Dial Transplant. 1997;12:1813-1816.
2. Collins AJ, Keane WF. Higher haematocrit levels: do they improve patient outcomes, and are they cost effective? Nephrol Dial Transplant. 1998;13:1627-1629.
3. Beusterien KM, Nissenson AR, Port FK, Kelly M, Steinwald B, Ware JE. The effects of recombinant human erythropoietin on functional health and well-being in chronic dialysis patients. J Am Soc Nephrol. 1996;7:763-773.
4. McMahon LP, McKenna MJ, Sangkabutra T, et al. Effects of haemoglobin normalization on quality of life and cardiovascular parameters in end-stage renal failure. Nephrol Dial Transplant. 2000;15:1425-1430.
5. Furuland H, Linde T, Ahlmen J, Christensson A, Strombom U, Danielson BG. A randomized controlled trial of haemoglobin normalization with epoetin alfa in pre-dialysis and dialysis patients. Nephrol Dial Transplant. 2003;18:353-361.
6. K/DOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis. 2006;47(suppl 3):S11-S145.
7. Singh AK, Szczech L, Tang KL, et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med. 2006;355:2085-2098.
8. Drueke TB, Locatelli F, Clyne M, et al. The normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med. 2006;355;2071-2084.
9. Movilli E, Pertica N, Camerini C, et al. Pre-dialysis versus post-dialysis hematocrit evaluation during erythpoietin therapy. Am J Kidney Dis. 2002;39:850-853.
10. Korzets A, Ori Y, Zevin D, Gafter U. Posthemodialysis hemoglobin levels: overdue or not? Am J Kidney Dis. 2002;40:873-874.
11. Agarwal R, Kelley K, Light RP. Diagnostic utility of blood volume monitoring in hemodialysis patients. Am J Kidney Dis. 2008;51:242-254.
12. Katz SD. Blood volume assessment in the diagnosis and treatment of chronic heart failure. Am J Med Sci. 2007;334(1):47-52.
13. Dunn A, Lo V, Donnelly, S. The role of the kidney in blood volume regulation: the kidney as a regulator of hematocrit. Am J Med Sci. 2007;334(1):6571.
14. Minutolo R, De Nicola L, Bellizzi V, et al. Intra- and post-dialytic changes of haemoglobin concentrations in non-anaemic haemodialysis patients. Nephrolog Dial Transplant. 2003;18:2606-2612.
15. Convertino VA. Blood volume response to physical activity. Am J Med Sci. 2007;334(1):72-79.